Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10745233rdf:typepubmed:Citationlld:pubmed
pubmed-article:10745233lifeskim:mentionsumls-concept:C0376574lld:lifeskim
pubmed-article:10745233lifeskim:mentionsumls-concept:C0019158lld:lifeskim
pubmed-article:10745233lifeskim:mentionsumls-concept:C0267797lld:lifeskim
pubmed-article:10745233lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:10745233lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:10745233lifeskim:mentionsumls-concept:C0022277lld:lifeskim
pubmed-article:10745233lifeskim:mentionsumls-concept:C1704788lld:lifeskim
pubmed-article:10745233pubmed:issue1lld:pubmed
pubmed-article:10745233pubmed:dateCreated2000-7-24lld:pubmed
pubmed-article:10745233pubmed:abstractTextThe role of GBV-C/HGV in the aetiology of acute non A-E hepatitis and its impact on the course of acute hepatitis of defined aetiology were investigated by detecting viral RNA by RT-PCR and antibody to the E2 protein of GB virus C (anti-E2) by EIA. Ninety-eight patients with acute nonA-E hepatitis, 35 patients with acute hepatitis A, 63 with acute hepatitis B, 29 with acute hepatitis C and 270 controls were enrolled in this study. The prevalence of GBV-C/HGV RNA was similar among patients with acute nonA-E hepatitis (3.1%), with acute hepatitis A (2.9%), and controls (3.7%), but significantly higher (P < 0.05) among those with hepatitis B or C (19.0% and 48.3%, respectively). Similar figures were obtained considering the total rate of GBV-C/HGV exposure (viral RNA or anti-E2 positivity). The majority (24/30 or 80%) of GBV-C/HGV RNA positive patients reported a parenteral source of exposure whereas the remaining 20% denied having known risk factors. The liver function test values and the rate of chronic hepatitis B and C were similar in patients co-infected and in those not co-infected with GBV-C/HGV. This study excludes a significant role of GBV-C/HGV infection in the aetiology of acute nonA-E hepatitis in Italy. Concomitant GBV-C/HGV and HBV or HCV infection does not worsen the clinical course of illness among patients with acute hepatitis.lld:pubmed
pubmed-article:10745233pubmed:languageenglld:pubmed
pubmed-article:10745233pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10745233pubmed:citationSubsetIMlld:pubmed
pubmed-article:10745233pubmed:statusMEDLINElld:pubmed
pubmed-article:10745233pubmed:monthMaylld:pubmed
pubmed-article:10745233pubmed:issn0146-6615lld:pubmed
pubmed-article:10745233pubmed:authorpubmed-author:MazzottaFFlld:pubmed
pubmed-article:10745233pubmed:authorpubmed-author:ZanettiA RARlld:pubmed
pubmed-article:10745233pubmed:authorpubmed-author:FabrisPPlld:pubmed
pubmed-article:10745233pubmed:authorpubmed-author:TanziEElld:pubmed
pubmed-article:10745233pubmed:authorpubmed-author:TosittiGGlld:pubmed
pubmed-article:10745233pubmed:authorpubmed-author:Roman?LLlld:pubmed
pubmed-article:10745233pubmed:copyrightInfoCopyright 2000 Wiley-Liss, Inc.lld:pubmed
pubmed-article:10745233pubmed:issnTypePrintlld:pubmed
pubmed-article:10745233pubmed:volume61lld:pubmed
pubmed-article:10745233pubmed:ownerNLMlld:pubmed
pubmed-article:10745233pubmed:authorsCompleteYlld:pubmed
pubmed-article:10745233pubmed:pagination59-64lld:pubmed
pubmed-article:10745233pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:meshHeadingpubmed-meshheading:10745233...lld:pubmed
pubmed-article:10745233pubmed:year2000lld:pubmed
pubmed-article:10745233pubmed:articleTitleGBV-C/hepatitis G virus in acute nonA-E hepatitis and in acute hepatitis of defined aetiology in Italy.lld:pubmed
pubmed-article:10745233pubmed:affiliationInstitute of Virology, University of Milan, Milan, Italy.lld:pubmed
pubmed-article:10745233pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10745233pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10745233lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10745233lld:pubmed